Cite
HARVARD Citation
Montagut, C. et al. (n.d.). 545PClinical impact of circulating tumor RAS and BRAF mutation dynamics in metastatic colorectal cancer patients treated with first-line chemotherapy plus anti-EGFR therapy: Combined analysis of two prospective clinical trials. Annals of oncology. p. . [Online].